Cerenome, Inc. (CNSY)
0.6301
-0.07
(-10.29%)
USD |
NASDAQ |
Nov 20, 16:00
0.6301
0.00 (0.00%)
After-Hours: 20:00
Cerenome Shareholders Equity (Quarterly) : -0.923M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.923M |
| June 30, 2026 | 5.463M |
| March 31, 2026 | 11.96M |
| December 31, 2025 | 3.996M |
| September 30, 2025 | 5.054M |
| June 30, 2025 | 3.034M |
| March 31, 2025 | -23.64M |
| December 31, 2024 | -8.949M |
| September 30, 2024 | -5.174M |
| June 30, 2024 | -7.625M |
| March 31, 2024 | -4.837M |
| December 31, 2023 | -1.348M |
| September 30, 2023 | 2.622M |
| June 30, 2023 | 2.662M |
| March 31, 2023 | 2.676M |
| December 31, 2022 | 6.445M |
| September 30, 2022 | 11.40M |
| June 30, 2022 | 9.679M |
| March 31, 2022 | 14.64M |
| December 31, 2021 | 10.84M |
| September 30, 2021 | 14.76M |
| June 30, 2021 | 11.94M |
| March 31, 2021 | 9.513M |
| December 31, 2020 | 3.031M |
| September 30, 2020 | 2.621M |
| Date | Value |
|---|---|
| June 30, 2020 | 3.30M |
| March 31, 2020 | 0.085M |
| December 31, 2019 | 1.16M |
| September 30, 2019 | 0.16M |
| June 30, 2019 | -6.276M |
| March 31, 2019 | 3.857M |
| December 31, 2018 | 5.225M |
| September 30, 2018 | 6.138M |
| June 30, 2018 | 4.751M |
| March 31, 2018 | 8.48M |
| December 31, 2017 | 13.00M |
| September 30, 2017 | 7.819M |
| June 30, 2017 | 11.23M |
| March 31, 2017 | 7.363M |
| December 31, 2016 | 10.99M |
| September 30, 2016 | 13.67M |
| June 30, 2016 | 18.72M |
| March 31, 2016 | 7.743M |
| December 31, 2015 | 12.21M |
| September 30, 2015 | 5.00M |
| June 30, 2015 | 2.26M |
| March 31, 2015 | -23.20M |
| December 31, 2014 | -5.702M |
| September 30, 2014 | -3.293M |
| June 30, 2014 | 1.193M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Ernexa Therapeutics, Inc. | 4.351M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.20M |
| Total Liabilities (Quarterly) | 13.12M |
| Debt to Equity Ratio | -4.313 |
| Current Ratio | 0.5496 |
| Net Debt Paydown Yield | -5.36% |